Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors

Journal of Immunology

Volumn 168, Issue 6, 2002, Pages 2795-2802

  Cunard, Robyn ^a   Ricote, Mercedes ^a   DiCampli, Dennis ^a   Archer, D Clay ^a   Kahn, Daniel A ^a   Glass, Christopher K ^a   Kelly, Carolyn J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD23 ANTIGEN; CD45 ANTIGEN; CIGLITAZONE; FIBRIC ACID DERIVATIVE; GAMMA INTERFERON; GW 7647; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; MITOGENIC AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIRINIXIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; T LYMPHOCYTE;

EID: 0037087324     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.6.2795     Document Type: Article

References (46)

1. The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation
2. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acy1 CoA oxidase gene
3. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
4. The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs
5. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
6. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism
7. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ)
8. 2 is a ligand for the adipocyte determination factor PPARγ
9. 4 pathway to inflammation control
10. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
11. Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages
12. A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response
13. Troglitazone prevents insulin dependent diabetes in the non-obese diabetic mouse
14. Peroxisome proliferator-activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor-deficient mice
15. Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice
16. Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: Pleiotropic effects on CD36 expression and HDL
17. Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-γ
18. The nuclear receptor PPARγ and immunoregulation: PPARγ mediates inhibition of helper T cell responses
19. Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor γ (PPARγ) agonists: PPARγ co-association with transcription factor NFAT
20. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
21. 2 inhibits multiple steps in the NF-κB signaling pathway
22. 2 in activated murine macrophages
23. PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation
24. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis
25. Combinatorial interactions between AP-1 and ets domain proteins contribute to the developmental regulation of the macrophage scavenger receptor gene
26. Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor γ and mediated by inhibition of translation initiation
27. Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-γ-mediated changes in gene expression
28. Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: A peroxisome proliferator-activated receptor-γ (PPARγ)-independent, antioxidant-related mechanism
29. Identification of a subtype selective human PPARα agonist through parallel-array synthesis
30. The nuclear receptor PPARγ is expressed by mouse T lymphocytes and PPARγ agonists induce apoptosis
31. + type I and type 2 T cells
32. Peroxisome proliferator-activated receptor a negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κB and AP-1
33. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
34. PPARα activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells
35. Constitutive activation of NF-κB in an animal model of aging
36. Induction of IκBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-a activators
37. Age-associated alterations in splenic iNOS regulation: Influence of constitutively expressed IFN-γ and correction following supplementation with PPARα activators or vitamin E
38. Role for peroxisome proliferator-activated receptor a in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells
39. Enhancement of common mucosal immunity in aged mice following their supplementation with various antioxidants
40. Peroxisome proliferator-activated receptors (PPAR) and the mitochondrial aldehyde dehydrogenase (ALDH2) promoter in vitro and in vivo
41. Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase
42. Interleukin-4-inhibited mRNA expression in mixed rat glial and in isolated microglial cultures
43. Clinical pharmacokinetics of fibric acid derivatives (fibrates)
44. Comparison of the effects of gemfibrozil and clofibric acid on peroxisomal enzymes and cholesterol synthesis of rat hepatocytes
45. 2 formation and characterization of its synthelases in various tissues of adult rats
46. 2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats